Liposomal anthracyclines for breast cancer: overview.
D018943:Anthracyclines / Q000008:administration & dosage* / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006333:Heart Failure / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D008081:Liposomes; D009362:Neoplasm Metastasis; D017239:Paclitaxel / Q000008:administration & dosage
D018943:Anthracyclines; D008081:Liposomes; D004317:Doxorubicin; D003520:Cyclophosphamide; D017239:Paclitaxel; D003630:Daunorubicin